As an important marker of brain injury, NfL has been tested and proposed as a promising biomarker of neuroaxonal injury in various neurodegenerative diseases, such as traumatic brain injury [25], subarachnoid hemorrhage [26], sports-related injury [27], military injury [28], and ageing-related changes [24]. This evidence concerns the gene NEFL and subarachnoid hemorrhage.